Skip to main content
Clinical Trials/NL-OMON37361
NL-OMON37361CompletedNot Applicable

Identification of a risk profile to guide atrial fibrillation therapy in patiens with AF - Risk stratification in AF

Academisch Medisch Centrum0 sites500 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
500

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • - Symptomatic paroxysmal or (long-standing) persistent AF;
  • - Rhythm control strategy is preferred;
  • - No contra-indication for oral anticoagulation;
  • - Age > 18 years;
  • - Written informed consent.

Exclusion Criteria

  • - Total history of heart failure and/ or of severe valvular disease > 10 years;
  • - Severe valvular disease;
  • - Acute coronary syndrome/ myocardial infarction/ percutaneous coronary intervention/ coronary artery bypass surgery within the past one month;
  • - Post-operative AF.

Investigators

Similar Trials